Recessive Oncogenes and Anti-Oncogenes

  • J. K. Cowell
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 94 / 2)

Abstract

The idea that inappropriate functions of specific genes can cause cancer has gained a lot of support from the study of acutely transforming retroviruses which carry oncogenes. Initially these oncogenes were isolated from avian retroviruses. Cellular homologues of these genes, termed proto-oncogenes, have been identified in eukaryotes. The demonstration that the introduction of activated oncogenes can confer a tumorigenic phenotype in certain cells has given rise to the concept that oncogenes act in a dominant manner. This appears to be true in chicken cells, for example, in which introduction of the src oncogene induces cancerous changes in host cells. This dominant transforming activity is not, however, a feature of all classes of genes that are involved in tumour development. Indeed, there is now a growing body of evidence to suggest that other classes of genes known as anti-oncogenes or suppressor genes may also function in the progressive series of events which leads to tumorigenesis.

Keywords

Somatic Cell Hybrid Deletion Carrier Human Gene Mapping Recessive Oncogene Bladder Epithelial Cell Line 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andersen S, Geertingen P, Larsen HW, Mikkelson M, Parbing A, Vestermark S, Warburg M (1978) Aniridia, cateract and gonadoblastoma in a mentally retarded girl with deletion of chromosome 11. Ophthalmologica 176:171–177Google Scholar
  2. Aviles D, Jami J, Rousset JP, Ritz E (1977) Tumour x host cell hybrids in the mouse: chromosomes from the normal parent maintained in malignant hybrid tumours. JNCI 58:1391–1397PubMedGoogle Scholar
  3. Balaban-Malenbaum G, Gilbert F, Nichols WW, Hill R, Shields J, Meadows AT (1981) A deleted chromosome number 13 in human retinoblastoma cells: relevance to tumorigenesis. Cancer Genet Cytogenet 3:243–250PubMedGoogle Scholar
  4. Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D, Bishop DT, Carey J, Baty B, Kivlin J, Willard H, Waye JS, Greig G, Leinwand L, Nakamura Y, O’Connell P, Leppert M, Lalouel JM, White R, Scolnick M (1987) Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 236:1100–1102PubMedGoogle Scholar
  5. Beckwith (1963) Extreme cytomegaly of the adrenal fetal cortex, omphalocele hyperplasia of kidneys and pancreas, and Leydig-cell hyperplasia: another syndrome? Western Soc Pediat Res, Los Angeles, Nov 11thGoogle Scholar
  6. Benedict WF, Murphree AL, Banerjee A, Spina CA, Sparkes MC, Sparkes RS (1983) Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene. Science 219:973–975PubMedGoogle Scholar
  7. Benedict WF, Srivatsan ES, Mark C, Banerjee A, Sparkes RS, Murphree AL (1987) Complete or partial homozygosity of chromosome 13 in primary retinoblastoma. Cancer Res 47:4189–4191PubMedGoogle Scholar
  8. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P, Lucibello FC, Mur-day VA, Rider SH, Scambler P, Sheer D, Solomon E, Spurr NK (1987) Localisation of the gene for familial adenomatous polyposis on chromosome 5. Nature 328:614–616PubMedGoogle Scholar
  9. Bruns GAP, Barnes SD, Gessler M, Brennick JB, Weiner MJ (1987) DNA probes for chromosome 11 and the WAGR deletion. Human Gene Mapping 9:240Google Scholar
  10. Cavenee W, Leach R, Mohandas T, Pearson P, White R (1984) Isolation and regional localisation of DNA segments revealing polymorphic loci for human chromosome 13. Am J Hum Genet 36:10–24PubMedGoogle Scholar
  11. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White R (1983) Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779–784PubMedGoogle Scholar
  12. Cavenee WK, Hansen MF, Nordenskjold M, Kock E, Maumenee I, Squire JA, Phillips RA, Gallie BL (1985) Genetic origin of mutations predisposing to retinoblastoma. Science 228:501–503PubMedGoogle Scholar
  13. Cavenee WK, Murphree AL, Schull MM, Benedict WF, Sparkes RS, Kock E, Nordenskjold M (1986) Prediction of familial predisposition to retinoblastoma. N Engl J Med 314: 1201–1207PubMedGoogle Scholar
  14. Cowell JK (1980) Consistent chromosome abnormalities associated with mouse bladder epithelial cell lines transformed in vitro. JNCI 65:955–961PubMedGoogle Scholar
  15. Cowell JK (1982) Appearance of double minute chromosomes in somatic cell hybridisation experiments involving the HAT selection system. Cell Biol Int Rep 6:393–399PubMedGoogle Scholar
  16. Cowell JK (1986) Manipulation of somatic cell hybrids for the analysis of the human genome. In: Rooney DE, Czepulkowski BH (eds) Humyn cytogenetics, a practical approach. IRL Press, Oxford, pp 202–218Google Scholar
  17. Cowell JK (1988) Molecular approaches towards the isolation of pediatric cancer predisposition genes. In: Kemshead JT (ed) Monoclonal antibodies and nuclear probes in childhood solid tumours. CRC Press, Boca RatonGoogle Scholar
  18. Cowell JK, Franks LM (1984) The ability of normal mouse cells to reduce the malignant potential of transformed mouse bladder epithelial cells depends on their somatic origin. Int J Cancer 33:657–667PubMedGoogle Scholar
  19. Cowell J, Rutland P, Jay M, Hungerford J (1986a) Deletions of the esterase-D locus from a survey of200 retinoblastoma patients. Hum Genet 72:164–167PubMedGoogle Scholar
  20. Cowell JK, Thompson E, Rutland P (1986b) The need to screen all retinoblastoma patients for esterase-D activity; detection of submicroscopic deletions. Arch Dis Child 62:8–11Google Scholar
  21. Cowell JK, Wadey RB, Pritchard J, Little PFR (1987a) Isolation and regional localisation of unique sequences from a chromosome 11 specific cosmid library. Human Gene Mapping 9:385Google Scholar
  22. Cowell JK, Hungerford J, Rutland P, Jay M (1987b) A chromosomal breakpoint which separates the esterase-D and retinoblastoma predisposition loci in a patient with del (13) (ql4-q31). Cancer Genet Cytogenet 27:27–31PubMedGoogle Scholar
  23. Cowell JK, Jay M, Rutland P, Hungerford J (1987c) An assessment of the usefulness of the esterase-D protein polymorphism in the antenatal prediction of retinoblastoma in the United Kingdom. Br J Cancer 55:661–664PubMedGoogle Scholar
  24. Cowell JK, Hungerford J, Jay M, Rutland P (1987d) Retinoblastoma-clinical and genetic aspects: a review. J Roy Soc Med 81:220–223Google Scholar
  25. Cowell JK, Hungerford J, Rutland P, Jay M (1989) Genetic and cytogenetic analysis of patients showing reduced esterase-D levels and mental retardation from a survey of 500 individuals with retinoblastoma. Ophthal Ped Genet 10:117–127Google Scholar
  26. Craig RW, Sager R (1985) Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells. Proc Natl Acad Sci USA 82:2062–2066PubMedGoogle Scholar
  27. Croce CM, Aden D, Koprowski H (1975) Tumorigenicity of mouse-man diploid hybrids in nude mice. Science 190:1200–1202PubMedGoogle Scholar
  28. Davis LM, Nowak NJ, Shows TB (1987) Seven new single copy DNA segments map to 1 lpl3. Human gene Mapping 9:69Google Scholar
  29. Douglass EC, Look AT, Webber B, Parham D, Wilimas JA, Green AA, Roberson PK (1986) Hyperdiploidy and chromosomal rearrangements define the anaplastic variant of Wilms’ tumour. J Clin Oncol 4:975–981PubMedGoogle Scholar
  30. Dracopoli NC, Houghton AN, Old LJ (1985) Loss of polymorphic restriction fragments in malignant melanoma: implications for tumour heterogeneity. Proc Natl Acad Sci USA 82:1470–1474PubMedGoogle Scholar
  31. Dracopoli NC, Alhadeff B, Houghton AN, Old LJ (1987) Loss of heterozygosity at autosomal and X-linked loci during tumour progression in a patient with melanoma. Cancer Res 47:3995–4000PubMedGoogle Scholar
  32. Dryja TP, Cavenee WK, White R, Rapaport JM, Peterson R, Albert DM, Bruns GA (1984) Homozygosity of chromosome 13 in retinoblastoma. N Engl J Med 310: 550–553PubMedGoogle Scholar
  33. Dryja TP, Rapaport JM, Epstein J, Goorin AM, Weichselbaum R, Koufos A, Cavenee WK (1986a) Chromosome 13 homozygosity in osteosarcoma without retinoblastoma. Am J Hum Genet 38:59–66PubMedGoogle Scholar
  34. Dryja TP, Rapaport JM, Joyce JM, Petersen RA (1986b) Molecular detection of deletions involving band ql4 of chromosome 13 in retinoblastomas. Proc Natl Acad Sci USA 83:7391–7394PubMedGoogle Scholar
  35. Duncan AMV, Morgan C, Gallie BL, Phillips RA, Squire J (1987) Re-evaluation of the sublocalisation of esterase-D and its relation to the retinoblastoma locus by in situ hybridisation. Cytogenet Cell Genet 44:153–157PubMedGoogle Scholar
  36. Erikson J, Williams DL, Finan J, Nowell PC, Croce CM (1985) Locus of the a-chain of the T-cell receptor is split by chromosome translocation in T-cell leukemias. Science 229: 784–786PubMedGoogle Scholar
  37. Evans EP, Burtenshaw MD, Brown BB, Hennion R, Harris H (1982) The analysis of malignancy by cell fusion. IX. Reexamination and clarification of the cytogenetic problem. J Cell Sci 56:113–130PubMedGoogle Scholar
  38. Fearon ER, Vogelstein B, Feinberg AP (1984) Somatic deletion and duplication of genes on chromosome 11 in Wilms’ tumours. Nature 309:176–178PubMedGoogle Scholar
  39. Franks LM (1982) The use of cell hybrids to study phenotypic expression in ageing and tumour cells. In: Celis JE (ed) Gene expression in normal and transformed cells. Plenum, New YorkGoogle Scholar
  40. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643–646PubMedGoogle Scholar
  41. Fung YT, Murphree AL, TAng A, Qian J, Hinrichs SH, Benedict WF (1987) Structural evidence for the authenticity of the human retinoblastoma gene. Science 236:1657–1661PubMedGoogle Scholar
  42. Gallie BL, Ellsworth RM, Abramson DH, Phillips RA (1982) Retinoblastoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation? Br J Cancer 45:513–521PubMedGoogle Scholar
  43. Geiser AG, Der CJ, Marshall CJ, Stanbridge EJ (1986) Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells. Proc Natl Acad Sci USA 83:5209–5213PubMedGoogle Scholar
  44. Glaser T, Lewis WH, Bruns GAP, Watkins PC, Rogler CE, Shows TB, Powers VE, Wil-lard HF, Goguen JM, Simola KOJ, Housman DE (1986) b-Subunit of follicle-stimulating hormone is deleted in patients with aniridia and Wilms’ tumour, allowing a further definition of the WAGR locus. Nature 321:882–887PubMedGoogle Scholar
  45. Godbout R, Dryja TP, Squire J, Gallie BL, Phillips RA (1983) Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma. Nature 304:451–453PubMedGoogle Scholar
  46. Grobstein C (1953) Morphogenetic interaction between embryonic mouse tissue separated by a membrane filter. Nature 172:869–871PubMedGoogle Scholar
  47. Haas OA, Zoubek A, Grumayer ER, Gadner H (1986) Constitutional interstitial deletion of llpll and pericentric inversion of chromosome 9 in a patient with Wiedemann-Beckwith syndrome and hepatoblastoma. Cancer Genet Cytogenet 23:95–104PubMedGoogle Scholar
  48. Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad O, Brogger A, Gedde-Dahl T, Cavenee WK (1985) Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition. Proc Natl Acad Sci USA 82:6216–6220PubMedGoogle Scholar
  49. Henry I, Grandjouan S, Azoulay M, Huerre-Jeanpierre C, Couillin P, Junien C (1987) Mitotic recombination with loss of heterozygosity distal to FSHB in a WAGR associated nephroblastoma. Human Gene Mapping 9:628Google Scholar
  50. Hopkinson DA, Mestriner MA, Cortner J, Harris H (1973) Esterase-D: a new human polymorphism. Ann Hum Genet 37:119–137PubMedGoogle Scholar
  51. Huerre-Jeanpierre C, Azoylay M, Henry I, Serre JL, Lavedan C, Coullin P, Antignac C, Salles AM, Lewis WH, Glaser T, Bernheim A, Junien C (1987) Malformative syndromes and predisposition to tumour: isolation and localisation of lip markers. Human Gene Mapping 9:489Google Scholar
  52. Jay M, Cowell JK, Hungerford J (1988) Register of retinoblastoma: preliminary results. Eye 2:102–105PubMedGoogle Scholar
  53. Junien C, Turleau C, De Grouchy J, Said R, Rethore MO, Tenconi R, Dufier JL (1980) Regional assignment of catalase(CAT) gene to band 11 pi 3. Association with the aniridia-Wilms’ tumour-gonadoblastoma (WAGR) complex. Ann Genet 28:165–168Google Scholar
  54. Kaneko Y, Euges MC, Rowley JD (1981) Interstitial deletion of short arm of chromosome 11 limited to Wilms’ tumour cells in a patient without aniridia. Cancer Res 41: 4577–4578PubMedGoogle Scholar
  55. Kaneko Y, Kondo K, Rowley JD, Moohr JW, Maurer HS (1983) Further chromosome studies on Wilms’ tumour cells of patients without aniridia. Cancer Genet Cytogenet 10:191–197PubMedGoogle Scholar
  56. Klinger H, Shows T (1983) Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells. JNCI 71:559–569PubMedGoogle Scholar
  57. Klinger HP (1980) Suppression of malignancy in somatic cell hybrids. I. Suppression and reexpression of tumorigenicity in diploid human x D98AH2 hybrids and independent segregation of tumorigenicity from other cell phenotypes. Cytogenet Cell Genet 27: 254–266PubMedGoogle Scholar
  58. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sei USA 68:820–823Google Scholar
  59. Knudson AG (1985) Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 45: 1437–1443PubMedGoogle Scholar
  60. Knudson AG (1986) Genetics of human cancer. Ann Rev Genet 20:231–251PubMedGoogle Scholar
  61. Knudson AG, Strong LC (1972) Mutation and cancer: a model for Wilms’ tumour of the kidney. JNCI 40:313–324Google Scholar
  62. Kondo K, Chilcote RR, Maurer HS, Rowley J (1984) Chromosome abnormalities in tumour cells from patients with sporadic Wilms’ tumour. Cancer Res 44:5376–5381PubMedGoogle Scholar
  63. Koufos A, Hansen MF, Lampkin BC, Workman ML, Copeland NG, Jenkins NA, Cavenee WK (1984) Loss of alleles at loci on human chromosome 11 during genesis of Wilms’ tumour. Nature 309:170–172PubMedGoogle Scholar
  64. Koufos A, Hansen MF, Copeland NG, Jenkins MA, Lampkin BC, Cavenee WK (1986) Loss of heterozygosity in 3 embryonal tumours suggests a common pathogenetic mechanism. Nature 316:330–334Google Scholar
  65. Kucherlapati R, Shin S (1979) Genetic control of tumorigenicity in interspecific mammalian cell hybrids. Cell 16:639–648PubMedGoogle Scholar
  66. Kusnetsova LE, Prigogina EL, Pogosianz HE, Belkina BM (1982) Similar chromosome abnormalities in several retinoblastomas. Hum Genet 61:201–204PubMedGoogle Scholar
  67. Lalande M, Dryja TP, Schreck RR, Shipley J, Flint A, Latt SA (1984) Isolation of human chromosome 13-specific DNA sequences cloned from flow sorted chromosomes and potentially linked to the retinoblastoma locus. Cancer Genet Cytogenet 13:283–295PubMedGoogle Scholar
  68. Lee WH, Murphree AL, Benedict WF (1985) Expression and amplification of the N-myc gene in primary retinoblastoma. Nature 309:458–460Google Scholar
  69. Lee WH, Bookstein R, Hong F, Young L, Shew JY, Lee EP (1987a) Human retinoblastoma susceptibility gene: cloning, identification and sequence. Science 235:1394–1399PubMedGoogle Scholar
  70. Lee WH, Bookstein R, Wheatley W, Benedict WF, Lee EP (1987b) A null allele of ester-ase-D is a marker for genetic events in retinoblastoma formation. Hum Genet 76:33–36PubMedGoogle Scholar
  71. Lee WH, Shew JY, Hong FD, Sery TW, Donoso LA, Young LJ, Bookstein R, Lee YP (1987c) The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 329:642–645PubMedGoogle Scholar
  72. Lele KP, Penrose LS, Stallard HB (1963) Chromosome deletion in a case of retinoblastoma. Ann Hum Genet 27:171–174PubMedGoogle Scholar
  73. Lewis WH, Yeger H (1987) Characterisation of the aniridia-Wilms’ tumour association region from chromosome lip. Human Gene Mapping 9:72Google Scholar
  74. Lewis WH, Goguen JM, Powers VE, Willard HF, Michalopoulos EE (1985) Gene order on the short arm of human chromosome 11: regional assignment of the LDH A gene distal to catalase in two translocations. Hum Genet 71:249–253PubMedGoogle Scholar
  75. Lundberg C, Skoog L, Cavenee WK, Nordenskjold M (1987) Loss of heterozygosity in human ductal breast tumours indicates a recessive mutation on chromosome 13. Proc Natl Acad Sci USA 84:2372–2376PubMedGoogle Scholar
  76. Mathew CGP, Chin KS, Easton EF, Thorpe K, Carter C, Liou GI, Fong S-L, Bridges CDB, Haak H, Nieuwenhuijzen Kruseman AC, Schifter S, Hansen HH, Telenius H, Telenuis-Berg M, Ponder BAJ (1987) A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328:527–528PubMedGoogle Scholar
  77. McCusick VA (1983) Mendelian inheritance in man, 6th edn. Johns Hopkins University Press, BaltimoreGoogle Scholar
  78. Miller RW (1964) Association of Wilms’ tumour with aniridia, hemihypertrophy and other congenital malformations. N Engl J Med 270:922PubMedGoogle Scholar
  79. Mooibroek H, Osinga J, Postmus PE, Carritt B, Buys CHMC (1987) Loss of heterozygosity for a chromosome 3 sequence presumably at 3p21 in small cell lung cancer. Cancer Genet Cytogenet 27:361–365PubMedGoogle Scholar
  80. Narahara K, Kikkawa K, Kimira S, Kimoto H, Ogata M, Kasai M, Matsuoka K (1984) Regional mapping of catalase and Wilms’ tumour-aniridia, genitourinary abnormalities, and mental retardation triad loci to the chromosome segment llpl305-pl 306. Hum Genet 66:181–185PubMedGoogle Scholar
  81. Niesen PD, Zimmermann KA, Cotter SV, Gilbert F, Alt FW (1986) Enhanced expression of the N-myc gene in Wilms’ tumour. Cancer Res 46:6217–6222Google Scholar
  82. Noda M, Selinger Z, Scolnick EM, Bassin RH (1983) Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes. Proc Natl Acad Sci USA 80:5602–5606PubMedGoogle Scholar
  83. Orkin SH, Goldman DS, Sallan SE (1984) Development of homozygosity for chromosome lip markers in Wilms’ tumour. Nature 309:172–174PubMedGoogle Scholar
  84. Porteous DJ, Morten JEN, Cranston G, Fletcher JM, Mitchell A, van Heyningen V, Fantes JA, Boyd PA, Hastie ND (1986) Molecular and physical arrangements of human DNA in HRAS1-selected, chromosome-mediated transfectants. Mol Cell Biol 6:2223–2232PubMedGoogle Scholar
  85. Porteous DJ, Bickmore W, Hirst M, Boyd P, Little P, Gosden J, Hastie N (1987) Co transfer of defined genes and cloning of anonymous DNA markers following HRAS-1 selected chromosome mediated gene transfer. Human Gene Mapping 9:51Google Scholar
  86. Raizis AM, Becroft DM, Shaw RL, Reeve AE (1985) A mitotic recombination in Wilms’ tumour occurs between the parathyroid hormone locus and llpl3. Hum Genet 70: 344–346PubMedGoogle Scholar
  87. Riccardi VM, Eichner JE (1986) Neurofibromatosis: phenotype, natural history and pathogenesis. Johns Hopkins University Press, BaltimoreGoogle Scholar
  88. Riccardi VM, Sujansky E, Smith AC, Francke U (1978) Chromosome imbalance in the aniridia-Wilms’ tumour association: lip interstitial deletion. Pediatrics 61:604–610PubMedGoogle Scholar
  89. Sager R (1985) Genetic suppression of tumour formation. Adv Cancer Res 44:43–68PubMedGoogle Scholar
  90. Scheffer H, Van Der Lelie D, Aanstoot GH, Good N, Nienhaus AJ, Van Der Hout AH, Pearson PL, Buys CHCM (1986) A straightforward approach to isolate DNA sequences with potential linkage to the retinoblastoma gene. Hum Genet 74: 249–255PubMedGoogle Scholar
  91. Schimke RN (1984) Genetic aspects of multiple endocrine neoplasia. Ann Rev Med 35: 25–31PubMedGoogle Scholar
  92. Scott J, Cowell JK, Robertson ME, Priestley LM, Wadey R, Hopkins B, Pritchard J, Bell GI, Rail LB, Graham CF, Knott TJ (1985) Insulin-like growth factor-II gene expression in Wilms’ tumour and embryonic tissues. Nature 317:260–262PubMedGoogle Scholar
  93. Scrable HJ, Witte DP, Lampkin BC, Cavenee WK (1987) Chromosomal localisation of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 329: 645–647PubMedGoogle Scholar
  94. Seizinger BR, De La Monte S, Atkins L, Gusella JF, Martuza RL (1987) Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sei USA 84:5419–5423Google Scholar
  95. Simpson NE, Kidd KK, Goodfellow PJ, McDermid H, Myers S, Kidd JR, Jackson CE, Duncan AMY, Farrer LA, Brasch K, Castiglione C, Genel M, Gertner J, Greenberg CR, Gusella JF, Holden JJA, White BN (1987) Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328:528–530PubMedGoogle Scholar
  96. Slater RM (1986) The cytogenetics of Wilms’ tumour. Cancer Genet Cytogenet 19:37–41PubMedGoogle Scholar
  97. Slater RM, De Kraker J (1982) Chromosome number 11 and Wilms’ tumour. Cancer Genet Cytogenet 5:237–245PubMedGoogle Scholar
  98. Slater RM, De Kraker J, Voute PA, Delemare JFM (1985) A cytogenetic study of Wilms’ tumour. Cancer Genet Cytogenet 14:95–109PubMedGoogle Scholar
  99. Solomon E, Voss R, Hall V, Bodmer WF, Jass JR, Jeffreys AJ, Lucibello FC, Patel I, Rider SH (1987) Chromosome 5 allele loss in human colorectal carcinomas. Nature 328:616–619PubMedGoogle Scholar
  100. Sparkes RS, Sparkes MC, Wilson MG, Towner JW, Benedict W, Murphree AL, Yunis JJ (1980) Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13ql4. Science 208:1042–1044PubMedGoogle Scholar
  101. Sparkes RS, Murphree AL, Lingua RW, Sparkes MC, Field LL, Funderbuck S, Benedict WF (1983) Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase-D. Science 217:971–973Google Scholar
  102. Sparkes RS, Sparkes MC, Kalina RE, Pagon RA, Salk DJ, Disteche CM (1984) Separation of the retinoblastoma and esterase D loci in a patient with sporadic retinoblastoma and del (13)(ql4.1q22.3). Hum Genet 6:258–259Google Scholar
  103. Squire J, Gallie BL, Phillips RA (1985) A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma. Hum Genet 70:291–301PubMedGoogle Scholar
  104. Squire J, Goddard AD, Canton M, Becker A, Phillips RA, Gallie BL (1986) Tumour induction by the retinoblastoma mutation is independent of N-myc expression. Nature 322:555–557PubMedGoogle Scholar
  105. Stanbridge EJ (1976) Suppression of malignancy in human cells. Nature 260:17–20PubMedGoogle Scholar
  106. Stanbridge EJ, Flandermeyer RR, Daniels DW, Nelson-Rees WA (1981) Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids. Somatic Cell Genet 7:699–712PubMedGoogle Scholar
  107. Summerhays IC, Franks LM (1979) Effect of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro. JNCI 62:1017–1023Google Scholar
  108. Turleau C, De Grouchy J, Chavin-Colin F, Martelli H, Voyer M, Charlas R (1984a) Trisomy llpl5 and Beckwith-Wiedemann syndrome. A report of two cases. Hum Genet 67:219–221PubMedGoogle Scholar
  109. Turleau C, DeGrouchy J, Nihoul-Fekete C, Dufier JL, Chavin-Colin F, Junien C (1984b) Del 1 lpl3/nephroblastoma without aniridia. Hum Genet 67:455–456PubMedGoogle Scholar
  110. Vogel W (1979) The genetics of retinoblastoma. Hum Genet 52:1–54PubMedGoogle Scholar
  111. Ward P, Packman S, Loughman W, Sparkes M, Sparkes R, McMahon A, Gregory T, Ablin A (1984) Location of the retinoblastoma susceptibility gene(s) and the human esterase D locus. J Med Genet 21:92–95PubMedGoogle Scholar
  112. Waziri M, Patil SR, Hanson JW, Bartley JA (1983) Abnormality of chromosome 11 in patients with features of Beckwith-Wiedemann syndrome. J Pediatr 102:873–876PubMedGoogle Scholar
  113. Weissman BE, Stanbridge EJ (1983) Complementation of the tumorigenic phenotype in human cell hybrids. JNCI 70:667–672PubMedGoogle Scholar
  114. Weissman BE, Saxon PJ, Pasquale SR, Jones GR, Geiser AG, Stanbrodge EJ (1987) Introduction of a normal human chromosome 11 into a Wilms’ tumour cell line controls its tumorigenic expression. Science 236:175–180PubMedGoogle Scholar
  115. Whang-Peng J, Bunn JPA, Kao-Shan CS, Lee EC, Carney DN, Gazdar A, Minna JD (1982) A nonrandom chromosomal abnormality, del 3p(14–23), in human small cell lung cancer (SCLC). Cancer Genet Cytogenet 6:119–134PubMedGoogle Scholar
  116. Wiedemann HR (1964) Complexe malformatif familial avec hernie ombilicle et macroglos-sie; un syndrome nouveau? J Genet Hum 13:223–232PubMedGoogle Scholar
  117. Wiedemann HR (1983) Tumours and hemihypertrophy associated with Wiedemann-Beckwith syndrome. Eur J Pediatr 141:129Google Scholar
  118. Wiggs J, Nordenskjeld M, Yandell D, Rapaport J, Grondin V, Janson M, Werelius B, Petersen R, Craft A, Riedel K, Lieberfarb R, Walton D, Wilson W, Dryja TP (1988) Prediction of the risk of hereditary retinoblastoma using DNA polymorphisms within the retinoblastoma gene. N Engl J Med 318:151–157PubMedGoogle Scholar
  119. Williams DL, Look T, Melvin SL, Roberson PK, Dahl G, Flake T, Stass S (1984) New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukaemia. Cell 36:101–109PubMedGoogle Scholar
  120. Zankl H, Zang KD (1980) Correlations between clinical and cytogenetical data in 180 meningiomas. Cancer Genet Cytogenet 1:351–356Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • J. K. Cowell

There are no affiliations available

Personalised recommendations